<DOC>
	<DOCNO>NCT02184910</DOCNO>
	<brief_summary>It well-known atrophic gastritis major risk factor gastric cancer , lead variation serum level gastrin , pepsinogen ( PG ) I , PGII . We want assess effect age , sex , Helicobacter pylori status pepsinogen ( PG ) level atrophic gastritis whether gastric atrophy base PG test would improve H. pylori eradication .</brief_summary>
	<brief_title>Usefulness Serum Pepsinogen Gastrin Predictive Biomarker Atrophic Gastritis , Intestinal Metaplasia Gastric Cancer Korea</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Gastritis</mesh_term>
	<mesh_term>Gastritis , Atrophic</mesh_term>
	<mesh_term>Gastrins</mesh_term>
	<criteria>1. 19 year 2. patient gastrointestinal discomfort get esophagogastroduodenoscopy ( EGD ) health check 3. patient get procedure , endoscopic submucosal resection ( ESD ) early gastric cancer 1. gastrectomy history 2. advanced gastric cancer ( impossible get gastrectomy ) 3 . Helicobacter eradication history 4. patient chronic disease 5. cancer patient except gastric cancer within 6 month 6. perform study accord research 's decision 7. bleeding tendency ( ex . take antiplatelet agent , low platelet count abnormal coagulation time )</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>atrophic gastritis , pepsinogen , Helicobacter pylorus</keyword>
</DOC>